This document summarizes the transformation of the supply chain management at NYC Health and Hospitals Corporation (HHC). HHC is the largest municipal healthcare system in the US, serving 1.3 million patients annually. It was facing a $1 billion budget shortfall and needed to restructure its supply chain to reduce costs. The transformation established pillars like strategic sourcing, vendor management, and performance management to standardize processes and leverage the system's size. The results included over $8 million in supply savings in the first year and a projected $21.46 million in total annual savings from various initiatives. Key metrics were also implemented to track progress. The transformation of the supply chain was a critical part of HHC's "Road A
The document discusses value stream management in healthcare. It defines a value stream as all the activities involved in treating patients from arrival to discharge. It describes mapping value streams using current and future state value stream maps to identify waste and improvements. The goal is to link processes in a smooth continuous flow without interruptions. Key components of value stream management include selecting a value stream manager, using visual controls, and conducting real-time problem solving and continuous process improvement.
Bear Stearns 2003 Global Healthcare Conference Presentationfinance2
John Hammergren, CEO of McKesson Corporation, presented at the 2003 Bear Stearns Global Healthcare Conference. He outlined McKesson's mission to advance healthcare and success of its partners. McKesson offers comprehensive products and services across pharmaceutical distribution, medical supplies, automation technology, and clinical software. McKesson aims to leverage its size, customer base, and solutions to create value for customers and shareholders through improved quality, reduced costs, and sustained financial performance across its business segments.
Cytori provides regenerative medicine devices and cell therapy. Their Celution system extracts stem and regenerative cells from fatty tissue for soft tissue repair and cardiovascular disease applications. Recent highlights include expanded approval in Europe and initiating a heart attack trial in 2011. Cytori has a strong balance sheet with $60 million in cash and is pursuing near-term revenue growth from soft tissue applications while developing cardiovascular indications.
The document discusses the rising costs of healthcare and actions that have been taken to control costs. It notes that everyone who sponsors a healthcare plan faces a cost problem as average annual costs have increased significantly from 2000 to 2010. The document discusses various actions that plans and employers have taken to try to bring healthcare costs under control, such as wellness programs, pre-certification, and care management programs. However, costs continue to rise significantly each year. The document suggests examining provider reimbursements and charges, as there is a large variance in what different providers charge for the same services. Addressing rising provider costs may be one way to help control overall healthcare costs.
- The document is a company update and recommendation report by Catalyst Equity Research on Neptune Technologies & Bioressources Inc.
- The recommendation is to buy Neptune stock, with a target price increased to C$8.75 per share from a prior target of C$7.00.
- Neptune develops products based on omega-3 fatty acid phospholipids extracted from krill for nutraceutical, medical food, and OTC markets. A subsidiary, Acasti Pharma, is conducting a Phase II clinical trial for a drug candidate called CaPre aimed at chronic cardiovascular conditions.
Pistoia Alliance Oct 2009 (Presented At Cdd)Chris Waller
The Pistoia Alliance aims to foster pre-competitive collaborations in the pharmaceutical industry. It was formed in 2008 by several large pharmaceutical companies to address increasing R&D costs and decreasing productivity. The Pistoia Alliance works to standardize interfaces, simplify architectures, and centralize services through various projects and working groups. One such working group focuses on developing standards for electronic laboratory notebook query services to enable knowledge mining across organizations.
The company saw a 0.2% increase in energy consumption in 1Q12. Revenues increased 2.7% due to growth in residential and commercial classes, while EBITDA declined 42% due to higher energy purchase costs and expenses related to improving reliability metrics. Net income declined 60.9% due to increased regulatory costs. Operational cash generation declined 35% while debt levels remained comfortable.
The document discusses value stream management in healthcare. It defines a value stream as all the activities involved in treating patients from arrival to discharge. It describes mapping value streams using current and future state value stream maps to identify waste and improvements. The goal is to link processes in a smooth continuous flow without interruptions. Key components of value stream management include selecting a value stream manager, using visual controls, and conducting real-time problem solving and continuous process improvement.
Bear Stearns 2003 Global Healthcare Conference Presentationfinance2
John Hammergren, CEO of McKesson Corporation, presented at the 2003 Bear Stearns Global Healthcare Conference. He outlined McKesson's mission to advance healthcare and success of its partners. McKesson offers comprehensive products and services across pharmaceutical distribution, medical supplies, automation technology, and clinical software. McKesson aims to leverage its size, customer base, and solutions to create value for customers and shareholders through improved quality, reduced costs, and sustained financial performance across its business segments.
Cytori provides regenerative medicine devices and cell therapy. Their Celution system extracts stem and regenerative cells from fatty tissue for soft tissue repair and cardiovascular disease applications. Recent highlights include expanded approval in Europe and initiating a heart attack trial in 2011. Cytori has a strong balance sheet with $60 million in cash and is pursuing near-term revenue growth from soft tissue applications while developing cardiovascular indications.
The document discusses the rising costs of healthcare and actions that have been taken to control costs. It notes that everyone who sponsors a healthcare plan faces a cost problem as average annual costs have increased significantly from 2000 to 2010. The document discusses various actions that plans and employers have taken to try to bring healthcare costs under control, such as wellness programs, pre-certification, and care management programs. However, costs continue to rise significantly each year. The document suggests examining provider reimbursements and charges, as there is a large variance in what different providers charge for the same services. Addressing rising provider costs may be one way to help control overall healthcare costs.
- The document is a company update and recommendation report by Catalyst Equity Research on Neptune Technologies & Bioressources Inc.
- The recommendation is to buy Neptune stock, with a target price increased to C$8.75 per share from a prior target of C$7.00.
- Neptune develops products based on omega-3 fatty acid phospholipids extracted from krill for nutraceutical, medical food, and OTC markets. A subsidiary, Acasti Pharma, is conducting a Phase II clinical trial for a drug candidate called CaPre aimed at chronic cardiovascular conditions.
Pistoia Alliance Oct 2009 (Presented At Cdd)Chris Waller
The Pistoia Alliance aims to foster pre-competitive collaborations in the pharmaceutical industry. It was formed in 2008 by several large pharmaceutical companies to address increasing R&D costs and decreasing productivity. The Pistoia Alliance works to standardize interfaces, simplify architectures, and centralize services through various projects and working groups. One such working group focuses on developing standards for electronic laboratory notebook query services to enable knowledge mining across organizations.
The company saw a 0.2% increase in energy consumption in 1Q12. Revenues increased 2.7% due to growth in residential and commercial classes, while EBITDA declined 42% due to higher energy purchase costs and expenses related to improving reliability metrics. Net income declined 60.9% due to increased regulatory costs. Operational cash generation declined 35% while debt levels remained comfortable.
United Health Group UnitedHealth Group Business Overviewfinance3
UnitedHealth Group is a diversified healthcare company serving 52 million Americans. It has three core competencies: advanced technology, healthcare data and informatics, and care facilitation. It operates discrete businesses focused on specific market segments. It invests over $2.2 billion annually in technology, research, and development. It enhances access to services, leverages buying power for affordability, and provides support to access and manage care. It applies technology to streamline administration, drive quality and consistency, and speed interactions. It gathers and shares data to enable analyses and provide tools to monitor utilization and costs. It has experienced strong financial performance with revenue, earnings per share, and stock appreciation growing significantly over 15 years.
Pasi Leino :: Using XML standards for system integrationgeorge.james
The document discusses HL7, an international standard for exchanging healthcare information. Some key points:
- HL7 is a non-profit organization that has been developing standards since 1987 to enable interoperability between healthcare systems.
- The standards cover different levels of interoperability from process to semantic to operational data exchange.
- Common HL7 standards include messages (HL7 v2.x, v3), clinical documents (CDA), terminology (vocabulary bindings), and application programming interfaces.
- HL7 is widely adopted, with a 2000 study finding 80% of large US hospitals using it. Finland has also adopted HL7 standards nationally.
Taiwan Synthetic Rubber Corporation (TSRC) reported 3Q11 earnings that were in line with expectations and 32% above analyst consensus estimates. While revenue increased 1% quarter-over-quarter and 67% year-over-year, gross profits rose 3% quarter-over-quarter and 99% year-over-year. The analyst maintains a Buy rating and NT$97 target price, expecting TSRC to benefit from continued margin expansion as butadiene prices decline more than synthetic rubber product prices. Downside risks include lower-than-expected tire demand and high raw material prices.
Jeff Campbell, Executive Vice President and CFO of McKesson, presented at the Goldman Sachs Healthcare Conference on June 14, 2006. McKesson generated $88 billion in revenues in fiscal year 2006, with strong growth over the past six years. McKesson has leadership positions across pharmaceutical distribution, medical supplies, and healthcare IT. The company is well positioned for ongoing growth through leadership in growing areas of healthcare and long-term customer relationships.
Ecolab is a global leader in cleaning, sanitizing, pest elimination and maintenance products and services. It serves customers in over 140 countries across multiple business units including institutional, food & beverage, pest elimination, and others. Ecolab also has a joint venture with Henkel called Henkel-Ecolab that allows it to extend its global reach into Europe. Ecolab has over 7,800 sales and service associates worldwide and has experienced steady revenue growth and increasing stock prices over the past few years.
The document discusses the need for a new patient-centered primary care model and summarizes the key elements of the patient-centered medical home (PCMH) model. The PCMH model aims to improve healthcare quality and access while reducing costs through care coordination, a team-based approach, and payment reforms that support primary care practices. It has received attention from medical organizations, insurers, politicians, and the media as a promising alternative to the current healthcare system.
Care Transitions Across the Continuum kickoff presentation as presented by Paul Diaz, CEO, Kindred Healthcare and Ben Breier, President and COO, Kindred Healthcare.
This document summarizes Jeff Campbell's presentation at the Baird 2005 Growth Stock Conference on May 11, 2005. Campbell discusses McKesson's business segments, including strong financial results and growth in pharmaceutical and medical-surgical solutions. Provider Technologies has experienced challenges but investments in innovation are paying off. For fiscal year 2006, McKesson expects revenue growth and operating cash flow over $1 billion, excluding the impact of settling a securities class action lawsuit.
Sustainability and efficiency can seem like conflicting objectives in logistics. This document discusses some practical ways to improve sustainability through local traffic control, bundling shipments, variable parking pricing, and real-time route guidance using algorithms. It also examines how to decide between alternatives that are cheap but slow versus fast but expensive and polluting. Modelling supply chain performance can help optimize for integrated and sustainable operations by analyzing key indicators under different scenarios.
Tempo Participacoes is a Brazilian healthcare administration company with several business units including healthcare administration, dental HMO, and assistance services. It has grown organically and through 10 acquisitions since 2000. Recent acquisitions in the last 12 months include USS Assistance, Associl, Med-Lar, Oraltech, and Odonto Empresa, totaling R$250 million invested. Tempo integrated the USS acquisition within 6 months, realizing synergies of R$14 million in fixed costs and R$8.2 million in operational efficiencies. In November 2007, Tempo conducted an IPO on the Novo Mercado listing R$419.765 million in shares.
Everyone is accountable and expected to protect health information. The circle is large and encompasses many different organizations. Patient data is protected for a reason. Let’s look at some brief reminders:
110212 divulgação de resultados 4 t10 inglesMultiplus
1) Multiplus saw increases in points issued and redeemed in 4Q10 compared to 3Q10, along with higher gross billings.
2) They improved their breakage accounting methodology to better reflect a 12-month average ratio, lowering breakage liability and raising deferred revenue.
3) While points issued and gross billings grew, adjusted EBITDA declined in 4Q10 due to the breakage methodology change and higher points to be redeemed.
Jeff Campbell, Executive Vice President and CFO of McKesson, presented at the Lehman Brothers Annual Healthcare Conference on March 31, 2005. The presentation provided an overview of McKesson, including that it is the largest pharmaceutical distributor in the US, Canada, and Mexico. It also discussed McKesson's strategy to bring together clinical knowledge, process expertise, technology, and resources to fundamentally change the cost and quality of healthcare. The presentation included financial highlights showing year-over-year revenue growth of 14% for Q3 and 16% for the first nine months, but also a $1.2 billion securities litigation settlement charge in Q3.
Interaction Mining: the new frontier of Call Center AnalyticsVincenzo Pallotta
This document discusses using interaction mining to analyze call center data. It outlines how interaction mining can identify customer-oriented behaviors, root causes of problems, problematic customers, and best practices for dealing with customers. The document describes applying automatic argumentative analysis to call center conversations to label statements with discourse relations and argumentative labels. It evaluates this approach on meeting conversations, achieving 81% precision and 98% recall. Experiments applying these techniques to a corpus of 213 manually transcribed call center conversations are also discussed.
The report provides an equity analysis update on Emmaar Properties, a real estate developer in Dubai. It summarizes Emmaar's 2Q11 results, which showed revenue exceeding forecasts and net profit before a Dubai Bank write-off also exceeding expectations. Recurring revenue from Emmaar's portfolio maintained strong performance, reporting around Dh833m in line with 1Q11. However, revenue from property for sale was almost in line with expectations, driven by handovers of residential units.
This document provides an overview of commissioning for value in healthcare. It discusses highlighting unwarranted variation in quality, outcomes, activity and spend using tools like the NHS Atlas of Variation. It emphasizes empowering patients through shared decision making using decision aids. It also covers engaging clinicians and commissioners to shift from "rationing" to "rational commissioning" and using information and insights to drive action and sharing of best practices. The goal is to increase value by focusing on health outcomes relative to total costs.
The document discusses opportunities in the Indian healthcare industry and tertiary healthcare sector specifically. It outlines strengths, weaknesses, opportunities and threats for tertiary healthcare. The main competitors in Delhi are listed along with their number of hospitals, beds, and revenues. The document discusses ethical dilemmas in healthcare and different stages of moral development. It proposes a hybrid business model for the new hospital that incorporates both charity and corporate aspects. Finally, it outlines the basic strategic plan to open a single super specialty neuroscience hospital to address the large demand-supply gap in Delhi.
This document summarizes a virtual conference on market access in the era of specialty and biotech drugs. It notes that by 2016, 8 of the top 10 worldwide drugs will be specialty drugs. It also discusses industry trends of developing more targeted therapies, a substantial pipeline of specialty drugs, and the need to demonstrate value to payers facing high costs. Upcoming sessions at the conference will address recent payment developments like accountable care organizations, comparative effectiveness research, and CMS coverage policies.
McKesson Corporation Investor and Analyst Day Presentationfinance2
This document summarizes the agenda and presentations for McKesson's 2006 Investor Day. The agenda included presentations from John Hammergren, Chairman and CEO, Jeff Campbell, EVP and CFO, Paul Julian, EVP, Group President, and Pam Pure, EVP, President of MPT, followed by a Q&A session. McKesson is well-positioned in growing healthcare services markets and has a track record of strong financial performance. It has leading market positions across its Pharmaceutical Solutions, Medical-Surgical Solutions, and Provider Technologies segments. Healthcare spending and drug consumption are expected to continue rising driven by demographics, with an aging population requiring more medication.
The Camden Coalition of Healthcare Providers works to improve health outcomes for residents of Camden, NJ. It does so by collecting and analyzing local healthcare data to better understand high-cost patients and their needs. This allows the Coalition to develop targeted interventions and care management programs. Analysis of claims data reveals patterns of emergency department and inpatient use. The Coalition also works to integrate this data into customized tools to coordinate care for high-need individuals and measure the impact of its programs.
This document summarizes the services provided by Accountable Care Solutions Group (ACSG) to support Accountable Care Organizations (ACOs). ACSG utilizes the American Health Data Institute (AHDI) to provide data analytics, population health management, and cost/quality reporting. ACSG's patented population management processes can help ACOs manage healthcare costs and quality. ACSG can also support ACO infrastructure, operations, financial reporting, and deployment of employer-based population health programs.
United Health Group UnitedHealth Group Business Overviewfinance3
UnitedHealth Group is a diversified healthcare company serving 52 million Americans. It has three core competencies: advanced technology, healthcare data and informatics, and care facilitation. It operates discrete businesses focused on specific market segments. It invests over $2.2 billion annually in technology, research, and development. It enhances access to services, leverages buying power for affordability, and provides support to access and manage care. It applies technology to streamline administration, drive quality and consistency, and speed interactions. It gathers and shares data to enable analyses and provide tools to monitor utilization and costs. It has experienced strong financial performance with revenue, earnings per share, and stock appreciation growing significantly over 15 years.
Pasi Leino :: Using XML standards for system integrationgeorge.james
The document discusses HL7, an international standard for exchanging healthcare information. Some key points:
- HL7 is a non-profit organization that has been developing standards since 1987 to enable interoperability between healthcare systems.
- The standards cover different levels of interoperability from process to semantic to operational data exchange.
- Common HL7 standards include messages (HL7 v2.x, v3), clinical documents (CDA), terminology (vocabulary bindings), and application programming interfaces.
- HL7 is widely adopted, with a 2000 study finding 80% of large US hospitals using it. Finland has also adopted HL7 standards nationally.
Taiwan Synthetic Rubber Corporation (TSRC) reported 3Q11 earnings that were in line with expectations and 32% above analyst consensus estimates. While revenue increased 1% quarter-over-quarter and 67% year-over-year, gross profits rose 3% quarter-over-quarter and 99% year-over-year. The analyst maintains a Buy rating and NT$97 target price, expecting TSRC to benefit from continued margin expansion as butadiene prices decline more than synthetic rubber product prices. Downside risks include lower-than-expected tire demand and high raw material prices.
Jeff Campbell, Executive Vice President and CFO of McKesson, presented at the Goldman Sachs Healthcare Conference on June 14, 2006. McKesson generated $88 billion in revenues in fiscal year 2006, with strong growth over the past six years. McKesson has leadership positions across pharmaceutical distribution, medical supplies, and healthcare IT. The company is well positioned for ongoing growth through leadership in growing areas of healthcare and long-term customer relationships.
Ecolab is a global leader in cleaning, sanitizing, pest elimination and maintenance products and services. It serves customers in over 140 countries across multiple business units including institutional, food & beverage, pest elimination, and others. Ecolab also has a joint venture with Henkel called Henkel-Ecolab that allows it to extend its global reach into Europe. Ecolab has over 7,800 sales and service associates worldwide and has experienced steady revenue growth and increasing stock prices over the past few years.
The document discusses the need for a new patient-centered primary care model and summarizes the key elements of the patient-centered medical home (PCMH) model. The PCMH model aims to improve healthcare quality and access while reducing costs through care coordination, a team-based approach, and payment reforms that support primary care practices. It has received attention from medical organizations, insurers, politicians, and the media as a promising alternative to the current healthcare system.
Care Transitions Across the Continuum kickoff presentation as presented by Paul Diaz, CEO, Kindred Healthcare and Ben Breier, President and COO, Kindred Healthcare.
This document summarizes Jeff Campbell's presentation at the Baird 2005 Growth Stock Conference on May 11, 2005. Campbell discusses McKesson's business segments, including strong financial results and growth in pharmaceutical and medical-surgical solutions. Provider Technologies has experienced challenges but investments in innovation are paying off. For fiscal year 2006, McKesson expects revenue growth and operating cash flow over $1 billion, excluding the impact of settling a securities class action lawsuit.
Sustainability and efficiency can seem like conflicting objectives in logistics. This document discusses some practical ways to improve sustainability through local traffic control, bundling shipments, variable parking pricing, and real-time route guidance using algorithms. It also examines how to decide between alternatives that are cheap but slow versus fast but expensive and polluting. Modelling supply chain performance can help optimize for integrated and sustainable operations by analyzing key indicators under different scenarios.
Tempo Participacoes is a Brazilian healthcare administration company with several business units including healthcare administration, dental HMO, and assistance services. It has grown organically and through 10 acquisitions since 2000. Recent acquisitions in the last 12 months include USS Assistance, Associl, Med-Lar, Oraltech, and Odonto Empresa, totaling R$250 million invested. Tempo integrated the USS acquisition within 6 months, realizing synergies of R$14 million in fixed costs and R$8.2 million in operational efficiencies. In November 2007, Tempo conducted an IPO on the Novo Mercado listing R$419.765 million in shares.
Everyone is accountable and expected to protect health information. The circle is large and encompasses many different organizations. Patient data is protected for a reason. Let’s look at some brief reminders:
110212 divulgação de resultados 4 t10 inglesMultiplus
1) Multiplus saw increases in points issued and redeemed in 4Q10 compared to 3Q10, along with higher gross billings.
2) They improved their breakage accounting methodology to better reflect a 12-month average ratio, lowering breakage liability and raising deferred revenue.
3) While points issued and gross billings grew, adjusted EBITDA declined in 4Q10 due to the breakage methodology change and higher points to be redeemed.
Jeff Campbell, Executive Vice President and CFO of McKesson, presented at the Lehman Brothers Annual Healthcare Conference on March 31, 2005. The presentation provided an overview of McKesson, including that it is the largest pharmaceutical distributor in the US, Canada, and Mexico. It also discussed McKesson's strategy to bring together clinical knowledge, process expertise, technology, and resources to fundamentally change the cost and quality of healthcare. The presentation included financial highlights showing year-over-year revenue growth of 14% for Q3 and 16% for the first nine months, but also a $1.2 billion securities litigation settlement charge in Q3.
Interaction Mining: the new frontier of Call Center AnalyticsVincenzo Pallotta
This document discusses using interaction mining to analyze call center data. It outlines how interaction mining can identify customer-oriented behaviors, root causes of problems, problematic customers, and best practices for dealing with customers. The document describes applying automatic argumentative analysis to call center conversations to label statements with discourse relations and argumentative labels. It evaluates this approach on meeting conversations, achieving 81% precision and 98% recall. Experiments applying these techniques to a corpus of 213 manually transcribed call center conversations are also discussed.
The report provides an equity analysis update on Emmaar Properties, a real estate developer in Dubai. It summarizes Emmaar's 2Q11 results, which showed revenue exceeding forecasts and net profit before a Dubai Bank write-off also exceeding expectations. Recurring revenue from Emmaar's portfolio maintained strong performance, reporting around Dh833m in line with 1Q11. However, revenue from property for sale was almost in line with expectations, driven by handovers of residential units.
This document provides an overview of commissioning for value in healthcare. It discusses highlighting unwarranted variation in quality, outcomes, activity and spend using tools like the NHS Atlas of Variation. It emphasizes empowering patients through shared decision making using decision aids. It also covers engaging clinicians and commissioners to shift from "rationing" to "rational commissioning" and using information and insights to drive action and sharing of best practices. The goal is to increase value by focusing on health outcomes relative to total costs.
The document discusses opportunities in the Indian healthcare industry and tertiary healthcare sector specifically. It outlines strengths, weaknesses, opportunities and threats for tertiary healthcare. The main competitors in Delhi are listed along with their number of hospitals, beds, and revenues. The document discusses ethical dilemmas in healthcare and different stages of moral development. It proposes a hybrid business model for the new hospital that incorporates both charity and corporate aspects. Finally, it outlines the basic strategic plan to open a single super specialty neuroscience hospital to address the large demand-supply gap in Delhi.
This document summarizes a virtual conference on market access in the era of specialty and biotech drugs. It notes that by 2016, 8 of the top 10 worldwide drugs will be specialty drugs. It also discusses industry trends of developing more targeted therapies, a substantial pipeline of specialty drugs, and the need to demonstrate value to payers facing high costs. Upcoming sessions at the conference will address recent payment developments like accountable care organizations, comparative effectiveness research, and CMS coverage policies.
McKesson Corporation Investor and Analyst Day Presentationfinance2
This document summarizes the agenda and presentations for McKesson's 2006 Investor Day. The agenda included presentations from John Hammergren, Chairman and CEO, Jeff Campbell, EVP and CFO, Paul Julian, EVP, Group President, and Pam Pure, EVP, President of MPT, followed by a Q&A session. McKesson is well-positioned in growing healthcare services markets and has a track record of strong financial performance. It has leading market positions across its Pharmaceutical Solutions, Medical-Surgical Solutions, and Provider Technologies segments. Healthcare spending and drug consumption are expected to continue rising driven by demographics, with an aging population requiring more medication.
The Camden Coalition of Healthcare Providers works to improve health outcomes for residents of Camden, NJ. It does so by collecting and analyzing local healthcare data to better understand high-cost patients and their needs. This allows the Coalition to develop targeted interventions and care management programs. Analysis of claims data reveals patterns of emergency department and inpatient use. The Coalition also works to integrate this data into customized tools to coordinate care for high-need individuals and measure the impact of its programs.
This document summarizes the services provided by Accountable Care Solutions Group (ACSG) to support Accountable Care Organizations (ACOs). ACSG utilizes the American Health Data Institute (AHDI) to provide data analytics, population health management, and cost/quality reporting. ACSG's patented population management processes can help ACOs manage healthcare costs and quality. ACSG can also support ACO infrastructure, operations, financial reporting, and deployment of employer-based population health programs.
The document discusses the patient-centered medical home (PCMH) model of care. It provides three key points:
1) The participant will understand the important trend of PCMH in healthcare and be able to discuss the rationale and supporting evidence for PCMH.
2) The participant will understand how PCMH impacts patients, providers, and payers.
3) The speaker discloses that they work for IBM and will not discuss pharmaceuticals, medical procedures, or devices. They have received expenses from pharmaceutical companies to discuss PCMH.
The document provides tips for leading quality and safety improvements, noting that leaders need to prioritize high-cost problems, lead improvement processes using systematic methods, and monitor outcomes to evaluate savings and spread successful changes. It emphasizes using data to motivate improvements and setting measurable targets to track progress and savings from reductions in waste and avoidable harm.
Maureen Bisognano: An international perspective: Leading for better health careThe King's Fund
Maureen Bisognano, President and CEO, Institute for Healthcare Improvement, gives an international perspective on leading for better healthcare at The King's Fund Second Annual NHS leadership and Management Summit.
This document provides an overview of AmerisourceBergen's Investor Day presentation on December 11, 2008. It begins with forward-looking statements and risk factors. The agenda then outlines speakers and topics to be covered, including ABC's distribution and related services, generics, specialty distribution, health policy, packaging, and financial review. Key points are that ABC aims to be resilient through its diversification across drug distribution and services, focus on specialty drugs and generics, and investments in business transformation. It provides an update on FY2008 financial results and the current pharmaceutical market environment of slower but continued growth.
Joseph Dal Molin: Implementing VistA internationally: Myth-busting lessons fr...Nuffield Trust
In this slideshow Joseph Dal Molin, President of the E-cology Corporation and Chairman of WorldVistA, outlines Jordan’s health system and its approach to implementing VistA.
Joseph Dal Molin presented at the Nuffield Trust seminar: Sharing international experience: Is implementing the VA's electronic health record system an option for the NHS? in July 2012.
Andrew Street: The future of Payment by ResultsNuffield Trust
This document discusses payment by results (PbR) in the UK healthcare system. It notes that PbR has contributed to growth in elective care and reduced waiting times but has not facilitated large shifts from hospital to primary care. Independent sector treatment centers have made a minimal contribution at significant cost. There remain large unexplained variations in hospital costs and quality as well as avoidable mortality rates. The document recommends retaining targets, having the regulator use PbR more effectively, enabling GP consortia to focus on community/primary care, and accounting for variations in efficiency and performance.
The IDN engaged in a collaborative project with its GPO called "30 in 2" to reduce its $700M annual supply spend by $30M within 2 years. Through centralizing processes, aligning physicians, analyzing spend, and optimizing contracts and vendor relationships, they achieved $45M in savings within 11 months, with $30M already implemented. Key was creating a customer-centric centralized supply chain through cross-organizational collaboration and communication. This reduced supply expenses as a percentage of net operating revenue to the lowest levels in the past decade.
Owens & Minor is a leading distributor of medical supplies and a healthcare supply chain management company. In 2005, the company reported $4.8 billion in revenue. Owens & Minor serves hospitals, healthcare systems, government organizations, and individuals through a network of distribution centers. The company focuses on improving efficiency and lowering costs for customers through innovative supply chain management solutions focused on product, process, and people.
This document discusses considerations for launching a specialty product. It emphasizes the importance of demonstrating value through clinical and cost effectiveness data, ensuring patient access to therapy, and generating data to support value claims. It provides tips for defining goals, building an integrated team, and refining a launch strategy focused on these priorities. The strategy should consider innovative contracting, outcomes-based agreements, and communicating the right evidence to the right audiences. Overall, the document stresses that demonstrating value is critical for specialty product launches, especially with increased attention on healthcare costs.
This document discusses eHealth solutions and provides an example of an ePrescribing system implemented in Lombardy, Italy. It describes the value of using information technology in healthcare to improve outcomes and reduce costs. Key benefits of eHealth include improving prevention and treatment, reducing errors and duplication, and supporting a shift to primary and preventative care. The document also provides an overview of Oracle's eHealth platform and applications that can be used to build solutions like electronic prescribing, disease management systems, and health information exchanges.
As business, you have two choices: let rising healthcare costs continue to eat away at your profits – or do something about it. The old healthcare model does not work, and healthcare reform laws will not lower your costs. Employees are overweight, more susceptible to illness and chronic disease and have no understanding of the true costs of healthcare or even know how to find the best care. A new paradigm is needed to control rising healthcare costs. In the care setting, the traditional insurance models distort the reality of health care for its most important consumer – the patient. Employers should shift the paradigm to allow the patient to step above the fog and find themselves as powerful consumers with the ability to demand higher value and more cost-effective care.
HPRC and PGH hosted a pre-conference session at CleanMed 2017 focused on the realities of healthcare plastics recycling. The event included an overview of the issue, some of the work PGH and HPRC are doing to help increase healthcare recycling, and then some in-depth advice from the trenches from Mayo Clinic, HealthPartners, and Gundersen Health System. For more information, go to hprc.org.
Future of Market Access – a Pharma PerspectivePM Society
The document discusses the future of market access in the pharmaceutical industry from 2002-2022. It notes increasing demands on healthcare systems, financial challenges, and the need for innovation. The future will require different types of market access based on a country's resources. Pharmaceutical companies will need to focus on outcomes, value-based pricing, real-world data, new customers like health boards, and playing a larger role in healthcare beyond just products.
The Dynamic State of Physician-Hospital Alignment: Using Collaboration and St...Amy MacNulty
This document summarizes a presentation on physician-hospital alignment. It discusses the imperative for alignment given changes in the healthcare industry, including issues like physician shortages and aging. It outlines strategies that can strengthen alignment, such as collaboration, engagement, and ensuring goals are aligned. It also discusses perceptions of existing relationships between hospitals and physicians and how perceptions sometimes differ between roles. The presentation aims to help organizations recognize drivers of alignment and create physician alignment plans.
Similar to New York City Health & Hospitals Corporation (20)
This document summarizes a presentation about controlling services spend at UPMC, a $9 billion healthcare organization. It discusses implementing the sPro system to gain greater control and visibility over services spending. The goals are to reduce costs, enforce compliance, and effectively manage the entire process from request to payment. It provides an overview of sPro's capabilities and the project scope, methodology, and benefits of deploying it at UPMC. This includes configuring sPro to support different payment types, integrating it with other systems, and training users and suppliers on the new processes.
The document provides information about the Upper Midwest Consolidated Services Center (UMCSC), a supply network of 37 healthcare member organizations. The UMCSC was formed in 2008 to leverage members' collective purchasing power through centralized sourcing and contracting. To date, the UMCSC has approved 202 supplier agreements and generated over $75 million in savings for members. The UMCSC is governed by a membership structure that includes Class A, B, and C members who must each commit to annual purchasing requirements from UMCSC contracts.
The document discusses a collaboration between Mercy Hospital, ROi, and BD to implement GS1 Standards across their entire medical supply chain, from manufacturing to the patient bedside. This comprehensive integration enabled several benefits, including improved patient safety through more accurate product tracking, optimized supply chain operations through tools like Perfect Order compliance, and cost savings through reduced payment times and discrepancies. Key accomplishments included assigning standardized identifiers to all product levels and locations, sharing accurate data electronically, and uncovering issues that strengthened data quality. Lessons learned emphasized the importance of communication between partners throughout the transition.
Banner will work with clinicians and physicians to reduce costs by eliminating supply utilization variances and misalignments in accordance with its operating model. This initiative aims to transform the culture so that utilization management is an ongoing daily focus. Under a fixed reimbursement system like MS-DRG, Banner must reduce costs to improve profit margins per case. Reducing supply costs is one strategy to operate successfully under a fixed reimbursement structure.
Indiana University Health is a large healthcare system comprised of 20 hospitals and over 21,000 employees across Indiana. As the largest healthcare system in the state, it has a unique partnership with Indiana University School of Medicine. The system is focused on improving patient care, education, research, and community service. It aims to create a patient-centered model that promotes value-based care and coordinates services across its hospitals and physicians. To achieve this, it works on aligning incentives between clinical staff and administrators, standardizing products and processes, and reducing unnecessary costs and variation in care delivery.
The document discusses a perioperative case study involving efforts to reduce costs for several supply categories through standardization initiatives. It describes objectives to lower prices for suture, endomechanicals, trocars, mesh and topical adhesives. A methodology is outlined involving identifying categories, reviewing data, obtaining approvals, issuing an RFP, and clinical validation. Implementation involved planning, member conversions, and physician interactions. Outcomes included commitments from 9 of 11 members to convert to the supplier. Lessons learned focused on validation, involvement, communication and addressing competitive tactics.
The document discusses a value stream analysis conducted to reduce the amount of time nurses spend gathering supplies. It states that currently nurses on average spend 60 minutes per shift gathering supplies, walking 8,895 feet per shift. The desired goals are to reduce lost revenue by 50%, reduce nursing time spent gathering supplies by 50%, and reduce distance walked per shift gathering supplies by 50%. Several proposed solutions involve implementing supply chain and information technologies like electronic ordering and barcoding to improve efficiency.
This document summarizes a supply chain distribution and logistics improvement project at Northwestern Memorial Hospital. Key goals of the project were to centralize inventory management, automate replenishment, and reduce waste to optimize costs and inventory levels while ensuring product availability. The project included implementing an "implant store", barcode and RFID technology, and standardized processes. As results, expired inventory was reduced by over $200k, charge capture increased by over $3M, inventory value decreased by over $2M while turns increased by over 1, and clinical time spent on inventory fell from 46% to 1%.
SCORe is the organization responsible for supply chain management at Parkview Health. Its vision is to operate a collaborative, effective, and cost-efficient end-to-end supply chain that enables Parkview Health professionals to provide quality healthcare. SCORe aims to optimize purchases and contracts, manage inventory virtually, and focus on customer relationships through demand planning and portfolio management. It utilizes an integrated IT system and aims to provide an end-to-end supply chain solution for Parkview Health.
This document outlines St. Anthony's Medical Center's physician-driven approach to reducing supply costs. It discusses rising healthcare costs and the need to reduce spending on supplies. The key areas of focus are cardiac devices and accessories. The goals are to clinically and financially align providers with the facility, achieve benchmark pricing, sole source top product categories, and promote quality patient outcomes while reducing costs. The initiative involves physician commitment, a multidisciplinary team, vendor participation and controls, contracting, and transitioning products. The success story highlights how a physician-driven committee achieved over $2 million in first year savings through sole source contracts, standardizing products, reducing vendors and inventory, and improving processes.
The document discusses optimizing the nursing unit environment of care (EOC) through a collaborative process. The objectives are to make rapid, grassroots-enabled improvements to the work environment and deepen relationships between nursing and support services. A core team leads the overall effort, with a steering team and nurse champions leading optimizations in individual units. The scope includes optimizing space usage, supplies, support processes, and the patient environment. Changes will be implemented across various hospital units from June 2010 to February 2011.
The document discusses the supply chain success at University of Mississippi Health Care (UMHC), a large healthcare system located in Jackson, Mississippi. It outlines how UMHC integrated its supply chain departments, gained leadership buy-in, implemented technology solutions, and partnered with distributors and GPOs to realize significant cost savings, exceeding goals by year three of execution. The document provides tips for C-suite executives and supply chain professionals to collaborate and drive supply chain process improvements.
The document discusses Elizabeth (Betty) Gibula's role as Director of Procurement at Johns Hopkins Health System and how she has implemented e-sourcing to help do more with less resources. It describes the growth of Johns Hopkins Medicine, past and present purchasing structures, and the steps taken to implement an e-sourcing strategy, including developing requirements, terms and conditions, and requiring supplier responses before bid events. This has helped increase efficiency and savings.
This document provides a program update for supply chain management and custom projects at a Veterans Health Administration facility for the month ending October 2011. It includes charts showing increasing approved, implemented, and realized project numbers and savings over time. A breakdown of implementable savings by area is given, with the largest being surgery, drugs, and facilities. Progress toward team goals is outlined for various clinical and non-clinical support areas.
The document discusses custom surgical packs for 6 hospitals owned by Meridian Health and Raritan Bay Medical Center. It describes pain points around standardizing data, normalizing component information, and limited clinical and analytical resources for product trials and bids. It then outlines how MedPricer.com was used to conduct an e-bid process for 141 custom surgical packs with over 4,500 components, aggregating $3.7 million in annual spend. This resulted in time savings, 13.6% cost savings of over $2.54 million over the contract life, and service levels beginning before contracts were signed.
The Medical Center of Central Georgia implemented a Staff Injury Prevention Program called Minimal Lift to reduce staff injuries from patient handling. They partnered with Diligent to provide equipment, education, and support. After implementing the program, staff injuries decreased by 98.7% compared to the previous baseline. The program helped create a culture change around safe patient handling and increased awareness of injury prevention. Monthly scorecards showed units were scoring above 86% on average for adherence to the program.
The document outlines CHRISTUS Health's $30 million savings goal for FY10 through implementing initiatives across ten categories representing 71% of potential savings. It describes the key categories, accountability measures, and progress updates. Regional executives were responsible for overseeing goals and addressing obstacles. Regular reporting and meetings monitored performance and identified areas for improvement.
Rhode Island Hospital, Hasbro Children's Hospital, The Miriam Hospital, Newport Hospital, and Bradley Hospital are all part of the same healthcare system located in Rhode Island.
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...AyushGadhvi1
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
1. NYC Health and Hospitals Corporation
Supply Chain Management Transformation
Joseph Quinones
Franco Sagliocca, MBA, FACHE
Richard Olah, CMRP
2. 2
About HHC
• $6.7 billion integrated healthcare delivery system
• Largest municipal healthcare organization in the country
• MetroPlus is HHC’s own 400,000 member health plan
• Serves 1.3 million New Yorkers / year (475,000+ are uninsured)
• Provides medical, mental health and substance abuse services through:
▫ 11 acute care hospitals
▫ 4 four skilled nursing facilities
▫ 6 large diagnostic and treatment centers
▫ 70+ community based clinics
• HHC Health and Home Care also provides in-home services for New Yorkers
• 2008 recipient of the National Quality Forum
• 2008 recipient of The Joint Commission’s John M. Eisenberg Award for Innovation in
Patient Safety and Quality
4. 4
Grappling with the Magnitude of the Problem
$1,000,000
At a Million dollars
the questions and trade-offs are important but focused
$1,000,000,000
At a Billion dollars
the questions and trade-offs involve thousands of NYC residents
and entire communities
The imperative for change was very clear for everyone
5. 5
Supply Chain Management is Accountable
for Sustaining Financial Stability
• Hospitals are the central focus of our modern healthcare
system, where the most advanced scientific knowledge and
technology meet the vulnerability of patients in need of care. They
rival the busiest hotel or the most bustling airport in the logistics of
admitting and caring for patients 24/7, and often serve as research
labs and teaching institutions as well. These complex enterprises are
as challenging to manage as a global business, but most hospitals
struggle because they aren’t run enough like businesses, says John
Hammergren in his book, ―Skin in the Game.‖ (Part 2 of 5)
6. 6
Total Cost of Ownership…
is a philosophy for really understanding all supply chain related costs of doing business
with a particular supplier for a particular good or service
-World Class Supply Management, 2003
Price Paid for a Product or
Service
Acquisition Costs Logistics Cost Quality Equation
Inventory Costs Inventory Risk
Cost to Serve
6
12. 12
At the end of the day it’s all about…
EXCELLENT Patient Care
• The history of our healthcare system is an incredible story of
scientific and technological innovation, but its evolution is
incomplete. The gaps and disconnections can be addressed by
technologies already in existence, but they need to be widely and
consistently adopted. When advances in the following areas are put
into practice — transparency, connectivity, productivity and
efficiency, best practices, diagnostics, robotics, retail healthcare and
personalized medicine — we’ll be able to fulfill the promise of
putting the patient back into the center of care, says John
Hammergren in his book, ―Skin in the Game.‖ (Part 4 of 5)
13. 13
Savings
FY 2012 Savings Savings
Supply Savings (as of June 2011) Employee Redirection $ 2,240,000
Vendor Amount
Cardinal New Opportunities $ 2,000,000
NY blood & Service $ 3,422,631.00
Total $ 4,240,000
Braun IV Solutions and Sets $ 969,523.00
GE Savings on Preventive
$ 715,963.00
Maintenance Contract Physician Preference Items Savings
Cardinal Products $ 921,000.00 Orthopedics $ 2,000,000
Cardinal Growth Rebate $ 264,981.00
Surgical Solutions Scopes* $ 5,000,000
Citi Storage $ 650,000.00
US Surgical - Sutures Endomechanicals Conversion** $ 2,000,000
HWS Waste Amendment $ 215,000.00
Total $ 9,000,000
Braun Pump Savings Woodhull $ 115,750.00
Braun Pump Savings Coney $ 111,130.00 *Currently some use at Bellevue
**Currently some use at Bellevue and 100% use at Coney Island
Coney Second Year Warranty $ 75,000.00
Braun Second Year Warrnty $ 78,000.00
Met pumps savings $ 73,450.00
Projected Savings =
Met second Year Warrnty $ 48,750.00 $21.46M
Central Poly Savings Plastic $ 281,782.00
3 M SAVINGS $ 21,000.00
ARJO HUNTLEIGH $ 65,000.00
Contracts Media $ 192,384.89
Total: $ $8,221,344.89
16. 16
Overview: Project Description
• The Road Ahead is a restructuring initiative that HHC is undergoing to
become a more cost-effective, more efficient, and stronger organization. To
meet new economic demands, to rise to the challenges of delivering
healthcare today, and to plan for the future, HHC must act now.
• What are the goals of The Road Ahead?
▫ To streamline care delivery for greater efficiency
▫ To restructure and combine some services to lower costs while maintaining needed capacity
▫ To ensure that changes are as fair as possible to our patients, communities and staff
▫ To preserve our essential mission of affording broad access to the uninsured
• If HHC is to continue to fulfill our mission to all New Yorkers, we must reduce our
costs of providing care and we must become the healthcare provider that New
Yorkers will choose. There will be difficult choices ahead. While every step is not yet
clear, The Road Ahead begins now.
17. 17
Overview: Challenges
• HHC is facing extraordinary financial deficits. Specifically, we will have a budget shortfall
of more than $1 billion in fiscal year 2011 (which begins July 1, 2010) and in the following years thereafter. What does this
mean to us as an organization? It will mean that there is
not enough money in the budget to continue to work the way we do. This will require us to
re-think the way that we operate our facilities and provide much of our care.
We are facing this dire financial future for several reasons, among them:
▫ Reduced funding from state Medicaid reimbursement • Reduced funding from the Federal Government • Growing
numbers of patients without health insurance • Increased healthcare equipment costs
▫ Higher costs for pensions and other benefits
• In addition, it is clear that HHC has important operational challenges as well as financial ones. We need to do better to
leverage the size of our system through collaboration and greater standardization of best practices. And we need to design
our delivery of care process so that it is consistently as efficient and patient-centered as possible. Beyond our own budget
challenges, the intense competition in our healthcare world means that we must earn patient loyalty every day. To do that,
we must:
▫ Make sure that the services offered meet the needs of today’s HHC patient
▫ More effectively deliver a continuum of care across HHC services to serve patients responsively at all stages of their
lives and
▫ Work together better across work areas, teams, and facilities to improve patient safety and satisfaction
Given our significant budget constraints, we expect that there will be reductions and consolidations in programs and
staff. Making these changes will be difficult but necessary if HHC is to be able to sustain our mission. We must keep our
morale up and remember that HHC has successfully navigated tough times before. We will do it again.
18. 18
Overview: Purpose
• As part of The Road Ahead, one of the goals is for every HHC facility to
become more productive and more effective. We are already doing good
work toward these goals, using other HHC resources that rely on the
ingenuity and support of employees to succeed. Our efforts in support of
Breakthrough are an important demonstration of how HHC employees can
work together to identify and implement process improvements. These
efforts are already yielding positive results, new revenue, and cost savings.
• The continuing commitment to Patient Safety is another good example of
how HHC employees have taken personal responsibility for doing the right
thing.
• By supporting our staff and serving our patients better, we'll also meet
another important goal: We will see satisfaction increase and our hospitals,
clinics, and long-term care facilities become the healthcare choice that all
New Yorkers will make.
19. 19
Overview: Moving Forward
• In 2009, the Restructuring Steering Committee – leaders from across HHC – began analyzing, planning, and working to
identify options to be considered as part of The Road Ahead – HHC’s restructuring strategy. The Restructuring Steering
Committee met often, consulted with outside experts, and established a broad agenda for change. In the spring of 2010, the
Restructuring Steering Committee deliberated, reviewed, and evaluated a range of very specific options, some of which have
been selected, some of which were rejected. The decision-making process balanced the need for deep cost-containment
actions with concern and consideration for HHC employees, targeted opportunities for growth, and the importance of
preserving HHC’s historic mission to care for all.
• Most of the options that are finally chosen will become part of The Road Ahead and will be implemented over the next four
fiscal years, beginning with fiscal year 2011 (which starts on July 1). They will all be discussed in detail in the weeks to come,
as the City’s budget gets worked out, but they reflect the hard realities of NYC in 2010. Some changes will happen quickly;
others will take longer to develop and implement.
• We have already brought staffing down by 1,000 full-time jobs through attrition – not filling every job when employees have
retired or voluntarily left HHC – but we will not be able to solely rely on attrition in the future and, as programs are
consolidated, staffing levels will need to be reduced. Planned workforce reductions will occur after discussions with labor
representatives and their implementation will be consistent with our collective bargaining agreements and our Personnel
Rules and Regulations.
These painful steps have been carefully considered by our Restructuring Steering Committee — which includes
representation from all of our networks. The Restructuring Steering Committee thoroughly weighed proposed actions and
recommendations from Deloitte and made decisions that are as fair as possible to all of our facilities, communities, patients
and staff. All employees should know that HHC is still advocating strongly for fair and supportive treatment from all
government funding sources. On a positive note, our collective work through Breakthrough and other major operational
improvement efforts are projected to close more than $200 million of our budget gap in the next fiscal year.